Peginterferon plus Chinese herbal therapy is associated with a higher virological response than only peginterferon therapy in chronic hepatitis C View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2013-09-11

AUTHORS

D. Cheng, E. Liu, Y. Li, R. Liu, L. Bai, Y. Chen, Y. Wang, Y. Chu, M. Wu, G. Cheng, S. Zhao

ABSTRACT

Traditional Chinese herbal therapies are widely used for the treatment of chronic hepatitis C (CHC) in China and several Asian countries. The aim of this study was to perform a meta-analysis of randomized controlled trials (RCTs) comparing peginterferon therapy with peginterferon plus Chinese herbal therapy for the treatment of CHC. The Cochrane Central Register of Controlled Trials, Medline, Science Citation Index, EMBASE, China National Knowledge Infrastructure, Wanfang Database, and China Biomedical Database were searched to identify RCTs that evaluated the virological response of CHC patients to peginterferon therapy and peginterferon plus Chinese herbal therapy. We statistically combined data using a fixed-effects meta-analysis according to the intention-to-treat principle. The literature search yielded 905 studies and nine RCTs composed of 858 patients matched the selection criteria. Overall, sustained virological response (SVR) was significantly higher in patients treated with peginterferon plus Chinese herbs than in patients treated with peginterferon alone (81 % vs. 64 %, respectively; odds ratio, 2.60; 95 % confidence interval: 1.32–5.14; p < 0.05). A combined therapy of peginterferon plus Chinese herbs was also superior to peginterferon therapy in achieving an early viral response (EVR, 80 % vs. 70 %, respectively), a viral response at week 24 of treatment (82 % vs. 73 %, respectively), and end-of-treatment viral response (ETVR, 73 % vs. 62 %, respectively). The combined therapy resulted in fewer relapses, fewer adverse events, and more rapid alanine transaminase normalization; however, both treatments yielded a similar rapid viral response (RVR, 53 % vs. 57 %, respectively). The current evidence suggests that combined therapy of peginterferon plus Chinese herbs yields a higher viral response and results in fewer relapses and fewer adverse events than peginterferon therapy alone. More... »

PAGES

433-438

References to SciGraph publications

  • 2010-09-09. Treatment with peginterferon versus interferon in Chinese patients with chronic hepatitis C in EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1007/s10096-013-1973-y

    DOI

    http://dx.doi.org/10.1007/s10096-013-1973-y

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1044778033

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/24022094


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Clinical Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Adolescent", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Adult", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Drug Therapy, Combination", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Drugs, Chinese Herbal", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Female", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Hepatitis C, Chronic", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Interferon alpha-2", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Interferon-alpha", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Male", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Middle Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Polyethylene Glycols", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Randomized Controlled Trials as Topic", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Recombinant Proteins", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Young Adult", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "The Third Affiliated Hospital of the School of Medicine, Xi\u2019an Jiaotong University, Shaanxi, China", 
              "id": "http://www.grid.ac/institutes/grid.43169.39", 
              "name": [
                "Key Laboratory of Environment and Genes Related to Diseases of the Education Ministry, Xi\u2019an Jiaotong University School of Medicine, Shaanxi, China", 
                "Laboratory for Lipid Metabolism and Atherosclerosis, Xi\u2019an Jiaotong University Cardiovascular Research Center, 710061, Shaanxi, China", 
                "The Third Affiliated Hospital of the School of Medicine, Xi\u2019an Jiaotong University, Shaanxi, China"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Cheng", 
            "givenName": "D.", 
            "id": "sg:person.0656247150.94", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0656247150.94"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Laboratory for Lipid Metabolism and Atherosclerosis, Xi\u2019an Jiaotong University Cardiovascular Research Center, 710061, Shaanxi, China", 
              "id": "http://www.grid.ac/institutes/grid.43169.39", 
              "name": [
                "Key Laboratory of Environment and Genes Related to Diseases of the Education Ministry, Xi\u2019an Jiaotong University School of Medicine, Shaanxi, China", 
                "Laboratory for Lipid Metabolism and Atherosclerosis, Xi\u2019an Jiaotong University Cardiovascular Research Center, 710061, Shaanxi, China"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Liu", 
            "givenName": "E.", 
            "id": "sg:person.016446245112.43", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016446245112.43"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Laboratory for Lipid Metabolism and Atherosclerosis, Xi\u2019an Jiaotong University Cardiovascular Research Center, 710061, Shaanxi, China", 
              "id": "http://www.grid.ac/institutes/grid.43169.39", 
              "name": [
                "Laboratory for Lipid Metabolism and Atherosclerosis, Xi\u2019an Jiaotong University Cardiovascular Research Center, 710061, Shaanxi, China"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Li", 
            "givenName": "Y.", 
            "id": "sg:person.01101266316.28", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01101266316.28"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Laboratory for Lipid Metabolism and Atherosclerosis, Xi\u2019an Jiaotong University Cardiovascular Research Center, 710061, Shaanxi, China", 
              "id": "http://www.grid.ac/institutes/grid.43169.39", 
              "name": [
                "Laboratory for Lipid Metabolism and Atherosclerosis, Xi\u2019an Jiaotong University Cardiovascular Research Center, 710061, Shaanxi, China"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Liu", 
            "givenName": "R.", 
            "id": "sg:person.0641103675.96", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0641103675.96"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Laboratory for Lipid Metabolism and Atherosclerosis, Xi\u2019an Jiaotong University Cardiovascular Research Center, 710061, Shaanxi, China", 
              "id": "http://www.grid.ac/institutes/grid.43169.39", 
              "name": [
                "Laboratory for Lipid Metabolism and Atherosclerosis, Xi\u2019an Jiaotong University Cardiovascular Research Center, 710061, Shaanxi, China"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Bai", 
            "givenName": "L.", 
            "id": "sg:person.0707217075.15", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707217075.15"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Laboratory for Lipid Metabolism and Atherosclerosis, Xi\u2019an Jiaotong University Cardiovascular Research Center, 710061, Shaanxi, China", 
              "id": "http://www.grid.ac/institutes/grid.43169.39", 
              "name": [
                "Laboratory for Lipid Metabolism and Atherosclerosis, Xi\u2019an Jiaotong University Cardiovascular Research Center, 710061, Shaanxi, China"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Chen", 
            "givenName": "Y.", 
            "id": "sg:person.0720253721.55", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0720253721.55"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Laboratory for Lipid Metabolism and Atherosclerosis, Xi\u2019an Jiaotong University Cardiovascular Research Center, 710061, Shaanxi, China", 
              "id": "http://www.grid.ac/institutes/grid.43169.39", 
              "name": [
                "Laboratory for Lipid Metabolism and Atherosclerosis, Xi\u2019an Jiaotong University Cardiovascular Research Center, 710061, Shaanxi, China"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Wang", 
            "givenName": "Y.", 
            "id": "sg:person.0604025321.87", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0604025321.87"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Institute of Molecular Virology, Xi\u2019an Jiaotong University School of Medicine, Shaanxi, China", 
              "id": "http://www.grid.ac/institutes/grid.43169.39", 
              "name": [
                "Institute of Molecular Virology, Xi\u2019an Jiaotong University School of Medicine, Shaanxi, China"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Chu", 
            "givenName": "Y.", 
            "id": "sg:person.01132665065.66", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01132665065.66"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "The Third Affiliated Hospital of the School of Medicine, Xi\u2019an Jiaotong University, Shaanxi, China", 
              "id": "http://www.grid.ac/institutes/grid.43169.39", 
              "name": [
                "Key Laboratory of Environment and Genes Related to Diseases of the Education Ministry, Xi\u2019an Jiaotong University School of Medicine, Shaanxi, China", 
                "The Third Affiliated Hospital of the School of Medicine, Xi\u2019an Jiaotong University, Shaanxi, China"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Wu", 
            "givenName": "M.", 
            "id": "sg:person.0610133750.71", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0610133750.71"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "The Third Affiliated Hospital of the School of Medicine, Xi\u2019an Jiaotong University, Shaanxi, China", 
              "id": "http://www.grid.ac/institutes/grid.43169.39", 
              "name": [
                "Key Laboratory of Environment and Genes Related to Diseases of the Education Ministry, Xi\u2019an Jiaotong University School of Medicine, Shaanxi, China", 
                "The Third Affiliated Hospital of the School of Medicine, Xi\u2019an Jiaotong University, Shaanxi, China"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Cheng", 
            "givenName": "G.", 
            "id": "sg:person.0722565616.77", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0722565616.77"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Laboratory for Lipid Metabolism and Atherosclerosis, Xi\u2019an Jiaotong University Cardiovascular Research Center, 710061, Shaanxi, China", 
              "id": "http://www.grid.ac/institutes/grid.43169.39", 
              "name": [
                "Key Laboratory of Environment and Genes Related to Diseases of the Education Ministry, Xi\u2019an Jiaotong University School of Medicine, Shaanxi, China", 
                "Laboratory for Lipid Metabolism and Atherosclerosis, Xi\u2019an Jiaotong University Cardiovascular Research Center, 710061, Shaanxi, China"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Zhao", 
            "givenName": "S.", 
            "id": "sg:person.01217761561.81", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01217761561.81"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1007/s10096-010-1051-7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1048534807", 
              "https://doi.org/10.1007/s10096-010-1051-7"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2013-09-11", 
        "datePublishedReg": "2013-09-11", 
        "description": "Traditional Chinese herbal therapies are widely used for the treatment of chronic hepatitis C (CHC) in China and several Asian countries. The aim of this study was to perform a meta-analysis of randomized controlled trials (RCTs) comparing peginterferon therapy with peginterferon plus Chinese herbal therapy for the treatment of CHC. The Cochrane Central Register of Controlled Trials, Medline, Science Citation Index, EMBASE, China National Knowledge Infrastructure, Wanfang Database, and China Biomedical Database were searched to identify RCTs that evaluated the virological response of CHC patients to peginterferon therapy and peginterferon plus Chinese herbal therapy. We statistically combined data using a fixed-effects meta-analysis according to the intention-to-treat principle. The literature search yielded 905 studies and nine RCTs composed of 858 patients matched the selection criteria. Overall, sustained virological response (SVR) was significantly higher in patients treated with peginterferon plus Chinese herbs than in patients treated with peginterferon alone (81\u00a0% vs. 64\u00a0%, respectively; odds ratio, 2.60; 95\u00a0% confidence interval: 1.32\u20135.14; p\u2009<\u20090.05). A combined therapy of peginterferon plus Chinese herbs was also superior to peginterferon therapy in achieving an early viral response (EVR, 80\u00a0% vs. 70\u00a0%, respectively), a viral response at week 24 of treatment (82\u00a0% vs. 73\u00a0%, respectively), and end-of-treatment viral response (ETVR, 73\u00a0% vs. 62\u00a0%, respectively). The combined therapy resulted in fewer relapses, fewer adverse events, and more rapid alanine transaminase normalization; however, both treatments yielded a similar rapid viral response (RVR, 53\u00a0% vs. 57\u00a0%, respectively). The current evidence suggests that combined therapy of peginterferon plus Chinese herbs yields a higher viral response and results in fewer relapses and fewer adverse events than peginterferon therapy alone.", 
        "genre": "article", 
        "id": "sg:pub.10.1007/s10096-013-1973-y", 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1093599", 
            "issn": [
              "0934-9723", 
              "1435-4373"
            ], 
            "name": "European Journal of Clinical Microbiology & Infectious Diseases", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "3", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "33"
          }
        ], 
        "keywords": [
          "chronic hepatitis C", 
          "Chinese herbal therapy", 
          "peginterferon therapy", 
          "viral response", 
          "herbal therapy", 
          "virological response", 
          "hepatitis C", 
          "Chinese herbs", 
          "adverse events", 
          "combined therapy", 
          "treatment of CHC", 
          "treatment viral response", 
          "alanine transaminase normalization", 
          "rapid viral response", 
          "high virological response", 
          "Cochrane Central Register", 
          "early viral response", 
          "traditional Chinese herbal therapy", 
          "China National Knowledge Infrastructure", 
          "China Biomedical Database", 
          "National Knowledge Infrastructure", 
          "transaminase normalization", 
          "CHC patients", 
          "Central Register", 
          "week 24", 
          "treat principle", 
          "Controlled Trials", 
          "peginterferon", 
          "Wanfang Database", 
          "current evidence", 
          "therapy", 
          "patients", 
          "Knowledge Infrastructure", 
          "literature search", 
          "Science Citation Index", 
          "biomedical databases", 
          "RCTs", 
          "relapse", 
          "treatment", 
          "trials", 
          "Citation Index", 
          "response", 
          "selection criteria", 
          "herbs", 
          "EMBASE", 
          "MEDLINE", 
          "database", 
          "Asian countries", 
          "study", 
          "Register", 
          "events", 
          "aim", 
          "evidence", 
          "index", 
          "normalization", 
          "criteria", 
          "search", 
          "data", 
          "countries", 
          "end", 
          "intention", 
          "results", 
          "China", 
          "principles", 
          "infrastructure"
        ], 
        "name": "Peginterferon plus Chinese herbal therapy is associated with a higher virological response than only peginterferon therapy in chronic hepatitis C", 
        "pagination": "433-438", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1044778033"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1007/s10096-013-1973-y"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "24022094"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1007/s10096-013-1973-y", 
          "https://app.dimensions.ai/details/publication/pub.1044778033"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-11-24T20:58", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/article/article_608.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1007/s10096-013-1973-y"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10096-013-1973-y'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10096-013-1973-y'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10096-013-1973-y'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10096-013-1973-y'


     

    This table displays all metadata directly associated to this object as RDF triples.

    269 TRIPLES      21 PREDICATES      107 URIs      98 LITERALS      23 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1007/s10096-013-1973-y schema:about N1b3af281285e43189b57f372fb2a0d67
    2 N43d007577c754ba7931deb5440c41a13
    3 N4ef74716809e43a4921e8904052974d9
    4 N608705309de442c6b11ac34deeb22940
    5 N8eefb7e33ff64bcf8676a6f1da487971
    6 N8f0b4f4111a54773ad562004c8e35190
    7 N8fa551f45237402bbe239d0e38c77dfe
    8 N9783138e0e1748399fc2260bed2f41b4
    9 N9f82de03d7d843fdaa7b74f3f1f58d12
    10 Na3dae5384c224aae8efaac8d3121d94a
    11 Na80506467f2b4cf49513dde97fef6bf8
    12 Nb4d1a1c851d34dd9a8f633075e278d93
    13 Nc650ebaf1a7e413cb3f4ede1acaa6d83
    14 Ne3c17d3070f94105bd2fa596286b8701
    15 Ne59c6eb79c134dc6902f96852c8fcfcd
    16 Neb6c6f2e38ae429fa27af5f5344c6107
    17 anzsrc-for:11
    18 anzsrc-for:1103
    19 schema:author Nd132a9a452904246a1aab2273ec868c9
    20 schema:citation sg:pub.10.1007/s10096-010-1051-7
    21 schema:datePublished 2013-09-11
    22 schema:datePublishedReg 2013-09-11
    23 schema:description Traditional Chinese herbal therapies are widely used for the treatment of chronic hepatitis C (CHC) in China and several Asian countries. The aim of this study was to perform a meta-analysis of randomized controlled trials (RCTs) comparing peginterferon therapy with peginterferon plus Chinese herbal therapy for the treatment of CHC. The Cochrane Central Register of Controlled Trials, Medline, Science Citation Index, EMBASE, China National Knowledge Infrastructure, Wanfang Database, and China Biomedical Database were searched to identify RCTs that evaluated the virological response of CHC patients to peginterferon therapy and peginterferon plus Chinese herbal therapy. We statistically combined data using a fixed-effects meta-analysis according to the intention-to-treat principle. The literature search yielded 905 studies and nine RCTs composed of 858 patients matched the selection criteria. Overall, sustained virological response (SVR) was significantly higher in patients treated with peginterferon plus Chinese herbs than in patients treated with peginterferon alone (81 % vs. 64 %, respectively; odds ratio, 2.60; 95 % confidence interval: 1.32–5.14; p < 0.05). A combined therapy of peginterferon plus Chinese herbs was also superior to peginterferon therapy in achieving an early viral response (EVR, 80 % vs. 70 %, respectively), a viral response at week 24 of treatment (82 % vs. 73 %, respectively), and end-of-treatment viral response (ETVR, 73 % vs. 62 %, respectively). The combined therapy resulted in fewer relapses, fewer adverse events, and more rapid alanine transaminase normalization; however, both treatments yielded a similar rapid viral response (RVR, 53 % vs. 57 %, respectively). The current evidence suggests that combined therapy of peginterferon plus Chinese herbs yields a higher viral response and results in fewer relapses and fewer adverse events than peginterferon therapy alone.
    24 schema:genre article
    25 schema:isAccessibleForFree false
    26 schema:isPartOf N3840442745824dd1976834d1b02ae471
    27 Nb68dbdd8466141e28bc87348211ebb00
    28 sg:journal.1093599
    29 schema:keywords Asian countries
    30 CHC patients
    31 Central Register
    32 China
    33 China Biomedical Database
    34 China National Knowledge Infrastructure
    35 Chinese herbal therapy
    36 Chinese herbs
    37 Citation Index
    38 Cochrane Central Register
    39 Controlled Trials
    40 EMBASE
    41 Knowledge Infrastructure
    42 MEDLINE
    43 National Knowledge Infrastructure
    44 RCTs
    45 Register
    46 Science Citation Index
    47 Wanfang Database
    48 adverse events
    49 aim
    50 alanine transaminase normalization
    51 biomedical databases
    52 chronic hepatitis C
    53 combined therapy
    54 countries
    55 criteria
    56 current evidence
    57 data
    58 database
    59 early viral response
    60 end
    61 events
    62 evidence
    63 hepatitis C
    64 herbal therapy
    65 herbs
    66 high virological response
    67 index
    68 infrastructure
    69 intention
    70 literature search
    71 normalization
    72 patients
    73 peginterferon
    74 peginterferon therapy
    75 principles
    76 rapid viral response
    77 relapse
    78 response
    79 results
    80 search
    81 selection criteria
    82 study
    83 therapy
    84 traditional Chinese herbal therapy
    85 transaminase normalization
    86 treat principle
    87 treatment
    88 treatment of CHC
    89 treatment viral response
    90 trials
    91 viral response
    92 virological response
    93 week 24
    94 schema:name Peginterferon plus Chinese herbal therapy is associated with a higher virological response than only peginterferon therapy in chronic hepatitis C
    95 schema:pagination 433-438
    96 schema:productId Nc98287e838584baba34039309ad1177a
    97 Ne3813a7c32b44dbdbc35c5b9513f0d78
    98 Ne9261aa690b14ba08dd5126d818aa934
    99 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044778033
    100 https://doi.org/10.1007/s10096-013-1973-y
    101 schema:sdDatePublished 2022-11-24T20:58
    102 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    103 schema:sdPublisher N7679a2386c904883b30d10076d6fc101
    104 schema:url https://doi.org/10.1007/s10096-013-1973-y
    105 sgo:license sg:explorer/license/
    106 sgo:sdDataset articles
    107 rdf:type schema:ScholarlyArticle
    108 N1b3af281285e43189b57f372fb2a0d67 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    109 schema:name Humans
    110 rdf:type schema:DefinedTerm
    111 N2a5fc79617014f0496a8adf25d4726dc rdf:first sg:person.0722565616.77
    112 rdf:rest N8dd5b65f958449ee86da1325fe88364a
    113 N3840442745824dd1976834d1b02ae471 schema:volumeNumber 33
    114 rdf:type schema:PublicationVolume
    115 N398efc6324eb4c1a9b8abbeafb0fb870 rdf:first sg:person.0707217075.15
    116 rdf:rest Nc53151b5637345e9afd1a4ae672f0bcd
    117 N4164e34ee0324907ae103f500739b6bf rdf:first sg:person.01101266316.28
    118 rdf:rest Nb82acf51dd25459797f173df92d45cc8
    119 N43d007577c754ba7931deb5440c41a13 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    120 schema:name Randomized Controlled Trials as Topic
    121 rdf:type schema:DefinedTerm
    122 N4ef74716809e43a4921e8904052974d9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    123 schema:name Adult
    124 rdf:type schema:DefinedTerm
    125 N608705309de442c6b11ac34deeb22940 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    126 schema:name Hepatitis C, Chronic
    127 rdf:type schema:DefinedTerm
    128 N68483f19226f41fcb8f4f7099c8db513 rdf:first sg:person.0604025321.87
    129 rdf:rest Nb17ffbf6ae6e4eadaf47b1f46bbf1ed8
    130 N7411299064454836ad6f16ad7a160c5c rdf:first sg:person.0610133750.71
    131 rdf:rest N2a5fc79617014f0496a8adf25d4726dc
    132 N7679a2386c904883b30d10076d6fc101 schema:name Springer Nature - SN SciGraph project
    133 rdf:type schema:Organization
    134 N8dd5b65f958449ee86da1325fe88364a rdf:first sg:person.01217761561.81
    135 rdf:rest rdf:nil
    136 N8eefb7e33ff64bcf8676a6f1da487971 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    137 schema:name Middle Aged
    138 rdf:type schema:DefinedTerm
    139 N8f0b4f4111a54773ad562004c8e35190 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    140 schema:name Recombinant Proteins
    141 rdf:type schema:DefinedTerm
    142 N8fa551f45237402bbe239d0e38c77dfe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    143 schema:name Interferon-alpha
    144 rdf:type schema:DefinedTerm
    145 N9783138e0e1748399fc2260bed2f41b4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    146 schema:name Female
    147 rdf:type schema:DefinedTerm
    148 N9f82de03d7d843fdaa7b74f3f1f58d12 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    149 schema:name Male
    150 rdf:type schema:DefinedTerm
    151 Na3dae5384c224aae8efaac8d3121d94a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    152 schema:name Aged
    153 rdf:type schema:DefinedTerm
    154 Na80506467f2b4cf49513dde97fef6bf8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    155 schema:name Polyethylene Glycols
    156 rdf:type schema:DefinedTerm
    157 Nb17ffbf6ae6e4eadaf47b1f46bbf1ed8 rdf:first sg:person.01132665065.66
    158 rdf:rest N7411299064454836ad6f16ad7a160c5c
    159 Nb4d1a1c851d34dd9a8f633075e278d93 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    160 schema:name Drug Therapy, Combination
    161 rdf:type schema:DefinedTerm
    162 Nb68dbdd8466141e28bc87348211ebb00 schema:issueNumber 3
    163 rdf:type schema:PublicationIssue
    164 Nb82acf51dd25459797f173df92d45cc8 rdf:first sg:person.0641103675.96
    165 rdf:rest N398efc6324eb4c1a9b8abbeafb0fb870
    166 Nc53151b5637345e9afd1a4ae672f0bcd rdf:first sg:person.0720253721.55
    167 rdf:rest N68483f19226f41fcb8f4f7099c8db513
    168 Nc650ebaf1a7e413cb3f4ede1acaa6d83 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    169 schema:name Adolescent
    170 rdf:type schema:DefinedTerm
    171 Nc98287e838584baba34039309ad1177a schema:name pubmed_id
    172 schema:value 24022094
    173 rdf:type schema:PropertyValue
    174 Nd132a9a452904246a1aab2273ec868c9 rdf:first sg:person.0656247150.94
    175 rdf:rest Ne260dedce5154b8dbef1e033ffccffd5
    176 Ne260dedce5154b8dbef1e033ffccffd5 rdf:first sg:person.016446245112.43
    177 rdf:rest N4164e34ee0324907ae103f500739b6bf
    178 Ne3813a7c32b44dbdbc35c5b9513f0d78 schema:name dimensions_id
    179 schema:value pub.1044778033
    180 rdf:type schema:PropertyValue
    181 Ne3c17d3070f94105bd2fa596286b8701 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    182 schema:name Interferon alpha-2
    183 rdf:type schema:DefinedTerm
    184 Ne59c6eb79c134dc6902f96852c8fcfcd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    185 schema:name Drugs, Chinese Herbal
    186 rdf:type schema:DefinedTerm
    187 Ne9261aa690b14ba08dd5126d818aa934 schema:name doi
    188 schema:value 10.1007/s10096-013-1973-y
    189 rdf:type schema:PropertyValue
    190 Neb6c6f2e38ae429fa27af5f5344c6107 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    191 schema:name Young Adult
    192 rdf:type schema:DefinedTerm
    193 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    194 schema:name Medical and Health Sciences
    195 rdf:type schema:DefinedTerm
    196 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
    197 schema:name Clinical Sciences
    198 rdf:type schema:DefinedTerm
    199 sg:journal.1093599 schema:issn 0934-9723
    200 1435-4373
    201 schema:name European Journal of Clinical Microbiology & Infectious Diseases
    202 schema:publisher Springer Nature
    203 rdf:type schema:Periodical
    204 sg:person.01101266316.28 schema:affiliation grid-institutes:grid.43169.39
    205 schema:familyName Li
    206 schema:givenName Y.
    207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01101266316.28
    208 rdf:type schema:Person
    209 sg:person.01132665065.66 schema:affiliation grid-institutes:grid.43169.39
    210 schema:familyName Chu
    211 schema:givenName Y.
    212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01132665065.66
    213 rdf:type schema:Person
    214 sg:person.01217761561.81 schema:affiliation grid-institutes:grid.43169.39
    215 schema:familyName Zhao
    216 schema:givenName S.
    217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01217761561.81
    218 rdf:type schema:Person
    219 sg:person.016446245112.43 schema:affiliation grid-institutes:grid.43169.39
    220 schema:familyName Liu
    221 schema:givenName E.
    222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016446245112.43
    223 rdf:type schema:Person
    224 sg:person.0604025321.87 schema:affiliation grid-institutes:grid.43169.39
    225 schema:familyName Wang
    226 schema:givenName Y.
    227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0604025321.87
    228 rdf:type schema:Person
    229 sg:person.0610133750.71 schema:affiliation grid-institutes:grid.43169.39
    230 schema:familyName Wu
    231 schema:givenName M.
    232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0610133750.71
    233 rdf:type schema:Person
    234 sg:person.0641103675.96 schema:affiliation grid-institutes:grid.43169.39
    235 schema:familyName Liu
    236 schema:givenName R.
    237 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0641103675.96
    238 rdf:type schema:Person
    239 sg:person.0656247150.94 schema:affiliation grid-institutes:grid.43169.39
    240 schema:familyName Cheng
    241 schema:givenName D.
    242 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0656247150.94
    243 rdf:type schema:Person
    244 sg:person.0707217075.15 schema:affiliation grid-institutes:grid.43169.39
    245 schema:familyName Bai
    246 schema:givenName L.
    247 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707217075.15
    248 rdf:type schema:Person
    249 sg:person.0720253721.55 schema:affiliation grid-institutes:grid.43169.39
    250 schema:familyName Chen
    251 schema:givenName Y.
    252 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0720253721.55
    253 rdf:type schema:Person
    254 sg:person.0722565616.77 schema:affiliation grid-institutes:grid.43169.39
    255 schema:familyName Cheng
    256 schema:givenName G.
    257 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0722565616.77
    258 rdf:type schema:Person
    259 sg:pub.10.1007/s10096-010-1051-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048534807
    260 https://doi.org/10.1007/s10096-010-1051-7
    261 rdf:type schema:CreativeWork
    262 grid-institutes:grid.43169.39 schema:alternateName Institute of Molecular Virology, Xi’an Jiaotong University School of Medicine, Shaanxi, China
    263 Laboratory for Lipid Metabolism and Atherosclerosis, Xi’an Jiaotong University Cardiovascular Research Center, 710061, Shaanxi, China
    264 The Third Affiliated Hospital of the School of Medicine, Xi’an Jiaotong University, Shaanxi, China
    265 schema:name Institute of Molecular Virology, Xi’an Jiaotong University School of Medicine, Shaanxi, China
    266 Key Laboratory of Environment and Genes Related to Diseases of the Education Ministry, Xi’an Jiaotong University School of Medicine, Shaanxi, China
    267 Laboratory for Lipid Metabolism and Atherosclerosis, Xi’an Jiaotong University Cardiovascular Research Center, 710061, Shaanxi, China
    268 The Third Affiliated Hospital of the School of Medicine, Xi’an Jiaotong University, Shaanxi, China
    269 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...